Secondly, using an in vivo GFP imaging system to visualize the tumor [26], the tumor volume of CD133+ cannot be effectively diminished by IR treatment alone, cisplatin alone, or a combination of IR/cisplatin as compared to the same treatment of CD133− (Figure S3C). Here, PROM1 is linked to neoplasm.